Fluorine in PDB 3d2t: Human Transthyretin (Ttr) Complexed with Diflunisal
Protein crystallography data
The structure of Human Transthyretin (Ttr) Complexed with Diflunisal, PDB code: 3d2t
was solved by
S.K.Palaninathan,
J.W.Kelly,
J.C.Sacchettini,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.58 /
1.85
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
43.204,
85.265,
64.208,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
21.2 /
23.5
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human Transthyretin (Ttr) Complexed with Diflunisal
(pdb code 3d2t). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 8 binding sites of Fluorine where determined in the
Human Transthyretin (Ttr) Complexed with Diflunisal, PDB code: 3d2t:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
Fluorine binding site 1 out
of 8 in 3d2t
Go back to
Fluorine Binding Sites List in 3d2t
Fluorine binding site 1 out
of 8 in the Human Transthyretin (Ttr) Complexed with Diflunisal
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Human Transthyretin (Ttr) Complexed with Diflunisal within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F502
b:28.9
occ:0.25
|
FAT
|
A:1FL502
|
0.0
|
28.9
|
0.2
|
CAN
|
A:1FL502
|
1.4
|
27.8
|
0.2
|
CAI
|
A:1FL502
|
1.5
|
29.1
|
0.2
|
OAD
|
A:1FL502
|
2.4
|
29.6
|
0.2
|
CAM
|
A:1FL502
|
2.4
|
27.7
|
0.2
|
CAJ
|
A:1FL502
|
2.4
|
29.1
|
0.2
|
CAP
|
A:1FL502
|
2.5
|
29.1
|
0.2
|
CAO
|
A:1FL502
|
2.5
|
25.2
|
0.2
|
CAC
|
A:1FL502
|
2.8
|
30.3
|
0.2
|
CAH
|
A:1FL502
|
2.8
|
26.4
|
0.2
|
CAO
|
A:1FL502
|
2.9
|
28.0
|
0.2
|
CAP
|
A:1FL502
|
3.0
|
28.9
|
0.2
|
CAI
|
A:1FL502
|
3.2
|
27.5
|
0.2
|
CAF
|
A:1FL502
|
3.7
|
28.0
|
0.2
|
CAQ
|
A:1FL502
|
3.7
|
27.6
|
0.2
|
CAK
|
A:1FL502
|
3.7
|
28.3
|
0.2
|
CAH
|
A:1FL502
|
3.8
|
26.3
|
0.2
|
OAB
|
A:1FL502
|
3.9
|
30.3
|
0.2
|
CAG
|
A:1FL502
|
3.9
|
24.9
|
0.2
|
CAN
|
A:1FL502
|
4.1
|
27.2
|
0.2
|
CAQ
|
A:1FL502
|
4.1
|
28.6
|
0.2
|
CAR
|
A:1FL502
|
4.2
|
27.7
|
0.2
|
CAJ
|
A:1FL502
|
4.2
|
28.0
|
0.2
|
CAG
|
A:1FL502
|
4.3
|
27.8
|
0.2
|
FAE
|
A:1FL502
|
4.8
|
27.5
|
0.2
|
CAF
|
A:1FL502
|
4.9
|
27.4
|
0.2
|
CAM
|
A:1FL502
|
4.9
|
26.7
|
0.2
|
FAT
|
A:1FL502
|
4.9
|
33.2
|
0.2
|
OAD
|
A:1FL502
|
5.0
|
27.1
|
0.2
|
OAL
|
A:1FL502
|
5.0
|
29.8
|
0.2
|
CAR
|
A:1FL502
|
5.0
|
28.0
|
0.2
|
CAC
|
A:1FL502
|
5.0
|
27.4
|
0.2
|
|
Fluorine binding site 2 out
of 8 in 3d2t
Go back to
Fluorine Binding Sites List in 3d2t
Fluorine binding site 2 out
of 8 in the Human Transthyretin (Ttr) Complexed with Diflunisal
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Human Transthyretin (Ttr) Complexed with Diflunisal within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F502
b:33.2
occ:0.25
|
FAT
|
A:1FL502
|
0.0
|
33.2
|
0.2
|
CAQ
|
A:1FL502
|
1.2
|
28.6
|
0.2
|
CAN
|
A:1FL502
|
1.4
|
27.2
|
0.2
|
CAR
|
A:1FL502
|
2.0
|
28.0
|
0.2
|
CAM
|
A:1FL502
|
2.3
|
26.7
|
0.2
|
CAP
|
A:1FL502
|
2.4
|
28.9
|
0.2
|
CAO
|
A:1FL502
|
2.5
|
28.0
|
0.2
|
CAO
|
A:1FL502
|
3.0
|
25.2
|
0.2
|
CB
|
A:THR119
|
3.0
|
27.6
|
0.5
|
OG1
|
A:THR119
|
3.1
|
30.7
|
0.5
|
CAP
|
A:1FL502
|
3.1
|
29.1
|
0.2
|
CAH
|
A:1FL502
|
3.1
|
26.3
|
0.2
|
CAQ
|
A:1FL502
|
3.2
|
27.6
|
0.2
|
CAK
|
A:1FL502
|
3.3
|
27.9
|
0.2
|
CAI
|
A:1FL502
|
3.6
|
27.5
|
0.2
|
CAF
|
A:1FL502
|
3.6
|
27.4
|
0.2
|
CG2
|
A:THR119
|
3.7
|
24.0
|
0.5
|
CB
|
A:ALA108
|
3.7
|
26.6
|
1.0
|
CAH
|
A:1FL502
|
3.8
|
26.4
|
0.2
|
CAJ
|
A:1FL502
|
4.0
|
28.0
|
0.2
|
O
|
A:HOH542
|
4.1
|
40.7
|
1.0
|
CA
|
A:THR119
|
4.2
|
27.6
|
1.0
|
CAG
|
A:1FL502
|
4.2
|
24.9
|
0.2
|
CAN
|
A:1FL502
|
4.2
|
27.8
|
0.2
|
CAG
|
A:1FL502
|
4.3
|
27.8
|
0.2
|
CAI
|
A:1FL502
|
4.3
|
29.1
|
0.2
|
OAL
|
A:1FL502
|
4.4
|
27.1
|
0.2
|
CAR
|
A:1FL502
|
4.4
|
27.7
|
0.2
|
C
|
A:THR119
|
4.4
|
27.8
|
1.0
|
CG2
|
A:VAL121
|
4.5
|
30.6
|
1.0
|
O
|
A:THR119
|
4.5
|
27.0
|
1.0
|
N
|
A:THR119
|
4.6
|
27.7
|
1.0
|
FAE
|
A:1FL502
|
4.7
|
30.4
|
0.2
|
FAT
|
A:1FL502
|
4.9
|
28.9
|
0.2
|
N
|
A:ALA120
|
5.0
|
28.1
|
1.0
|
CA
|
A:ALA108
|
5.0
|
26.5
|
1.0
|
|
Fluorine binding site 3 out
of 8 in 3d2t
Go back to
Fluorine Binding Sites List in 3d2t
Fluorine binding site 3 out
of 8 in the Human Transthyretin (Ttr) Complexed with Diflunisal
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Human Transthyretin (Ttr) Complexed with Diflunisal within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F502
b:27.5
occ:0.25
|
FAE
|
A:1FL502
|
0.0
|
27.5
|
0.2
|
OAL
|
A:1FL502
|
0.4
|
29.8
|
0.2
|
CAF
|
A:1FL502
|
1.4
|
28.0
|
0.2
|
CAK
|
A:1FL502
|
1.4
|
28.3
|
0.2
|
CAG
|
A:1FL502
|
2.3
|
27.8
|
0.2
|
CAJ
|
A:1FL502
|
2.3
|
29.1
|
0.2
|
CAR
|
A:1FL502
|
2.4
|
27.7
|
0.2
|
CAM
|
A:1FL502
|
2.4
|
27.7
|
0.2
|
OAB
|
A:1FL502
|
2.7
|
30.3
|
0.2
|
CAC
|
A:1FL502
|
2.9
|
30.3
|
0.2
|
CD2
|
A:LEU110
|
3.1
|
25.4
|
1.0
|
CAI
|
A:1FL502
|
3.5
|
29.1
|
0.2
|
CAH
|
A:1FL502
|
3.5
|
26.3
|
0.2
|
CAQ
|
A:1FL502
|
3.6
|
27.6
|
0.2
|
CAN
|
A:1FL502
|
3.6
|
27.8
|
0.2
|
CB
|
A:SER117
|
3.9
|
28.2
|
1.0
|
CB
|
A:LEU110
|
4.0
|
25.1
|
1.0
|
CAP
|
A:1FL502
|
4.1
|
29.1
|
0.2
|
CAO
|
A:1FL502
|
4.2
|
25.2
|
0.2
|
CG
|
A:LEU110
|
4.2
|
24.6
|
1.0
|
OG
|
A:SER117
|
4.2
|
32.9
|
1.0
|
OAD
|
A:1FL502
|
4.3
|
29.6
|
0.2
|
FAT
|
A:1FL502
|
4.8
|
28.9
|
0.2
|
|
Fluorine binding site 4 out
of 8 in 3d2t
Go back to
Fluorine Binding Sites List in 3d2t
Fluorine binding site 4 out
of 8 in the Human Transthyretin (Ttr) Complexed with Diflunisal
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Human Transthyretin (Ttr) Complexed with Diflunisal within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F502
b:30.4
occ:0.25
|
FAE
|
A:1FL502
|
0.0
|
30.4
|
0.2
|
OAL
|
A:1FL502
|
0.8
|
27.1
|
0.2
|
CAF
|
A:1FL502
|
1.4
|
27.4
|
0.2
|
CAK
|
A:1FL502
|
1.6
|
27.9
|
0.2
|
CAJ
|
A:1FL502
|
2.2
|
28.0
|
0.2
|
OAB
|
A:1FL502
|
2.3
|
27.4
|
0.2
|
CAG
|
A:1FL502
|
2.4
|
24.9
|
0.2
|
CAM
|
A:1FL502
|
2.4
|
26.7
|
0.2
|
CAC
|
A:1FL502
|
2.6
|
27.4
|
0.2
|
CAR
|
A:1FL502
|
2.7
|
28.0
|
0.2
|
CAI
|
A:1FL502
|
3.4
|
27.5
|
0.2
|
CAH
|
A:1FL502
|
3.6
|
26.4
|
0.2
|
CAN
|
A:1FL502
|
3.6
|
27.2
|
0.2
|
CAQ
|
A:1FL502
|
3.8
|
28.6
|
0.2
|
OAD
|
A:1FL502
|
4.0
|
27.1
|
0.2
|
CAO
|
A:1FL502
|
4.2
|
28.0
|
0.2
|
CAP
|
A:1FL502
|
4.2
|
28.9
|
0.2
|
CG2
|
A:VAL121
|
4.4
|
30.6
|
1.0
|
FAT
|
A:1FL502
|
4.7
|
33.2
|
0.2
|
CD
|
A:LYS15
|
4.9
|
33.6
|
1.0
|
|
Fluorine binding site 5 out
of 8 in 3d2t
Go back to
Fluorine Binding Sites List in 3d2t
Fluorine binding site 5 out
of 8 in the Human Transthyretin (Ttr) Complexed with Diflunisal
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Human Transthyretin (Ttr) Complexed with Diflunisal within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F500
b:29.2
occ:0.25
|
FAT
|
B:1FL500
|
0.0
|
29.2
|
0.2
|
CAN
|
B:1FL500
|
1.4
|
27.2
|
0.2
|
CAI
|
B:1FL500
|
1.6
|
27.4
|
0.2
|
OAD
|
B:1FL500
|
2.3
|
27.4
|
0.2
|
CAM
|
B:1FL500
|
2.4
|
27.0
|
0.2
|
CAO
|
B:1FL500
|
2.5
|
27.5
|
0.2
|
CAJ
|
B:1FL500
|
2.5
|
27.6
|
0.2
|
CAP
|
B:1FL500
|
2.6
|
27.9
|
0.2
|
CAC
|
B:1FL500
|
2.8
|
27.6
|
0.2
|
CAO
|
B:1FL500
|
3.0
|
26.5
|
0.2
|
CAP
|
B:1FL500
|
3.0
|
27.3
|
0.2
|
CAH
|
B:1FL500
|
3.0
|
25.1
|
0.2
|
CAI
|
B:1FL500
|
3.2
|
27.4
|
0.2
|
CAF
|
B:1FL500
|
3.7
|
26.9
|
0.2
|
CAH
|
B:1FL500
|
3.8
|
27.6
|
0.2
|
CAK
|
B:1FL500
|
3.8
|
27.4
|
0.2
|
CAQ
|
B:1FL500
|
3.9
|
27.2
|
0.2
|
OAB
|
B:1FL500
|
4.0
|
27.2
|
0.2
|
CAG
|
B:1FL500
|
4.1
|
23.8
|
0.2
|
CAN
|
B:1FL500
|
4.1
|
26.8
|
0.2
|
CAQ
|
B:1FL500
|
4.1
|
26.7
|
0.2
|
CAJ
|
B:1FL500
|
4.2
|
27.8
|
0.2
|
CAG
|
B:1FL500
|
4.2
|
29.5
|
0.2
|
CAR
|
B:1FL500
|
4.3
|
27.1
|
0.2
|
FAE
|
B:1FL500
|
4.8
|
28.1
|
0.2
|
FAT
|
B:1FL500
|
4.9
|
29.7
|
0.2
|
OAD
|
B:1FL500
|
4.9
|
27.3
|
0.2
|
CAF
|
B:1FL500
|
5.0
|
27.2
|
0.2
|
CAC
|
B:1FL500
|
5.0
|
28.1
|
0.2
|
CAM
|
B:1FL500
|
5.0
|
26.5
|
0.2
|
|
Fluorine binding site 6 out
of 8 in 3d2t
Go back to
Fluorine Binding Sites List in 3d2t
Fluorine binding site 6 out
of 8 in the Human Transthyretin (Ttr) Complexed with Diflunisal
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Human Transthyretin (Ttr) Complexed with Diflunisal within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F500
b:29.7
occ:0.25
|
FAT
|
B:1FL500
|
0.0
|
29.7
|
0.2
|
CAQ
|
B:1FL500
|
1.2
|
26.7
|
0.2
|
CAN
|
B:1FL500
|
1.4
|
26.8
|
0.2
|
CAR
|
B:1FL500
|
1.8
|
26.4
|
0.2
|
CAM
|
B:1FL500
|
2.3
|
26.5
|
0.2
|
CAP
|
B:1FL500
|
2.4
|
27.3
|
0.2
|
CAO
|
B:1FL500
|
2.5
|
26.5
|
0.2
|
CB
|
B:THR119
|
3.1
|
29.6
|
1.0
|
CAP
|
B:1FL500
|
3.1
|
27.9
|
0.2
|
CAK
|
B:1FL500
|
3.1
|
27.1
|
0.2
|
CAO
|
B:1FL500
|
3.1
|
27.5
|
0.2
|
CAQ
|
B:1FL500
|
3.2
|
27.2
|
0.2
|
CG2
|
B:THR119
|
3.3
|
28.3
|
1.0
|
CAH
|
B:1FL500
|
3.4
|
27.6
|
0.2
|
CAI
|
B:1FL500
|
3.6
|
27.4
|
0.2
|
OG1
|
B:THR119
|
3.6
|
31.8
|
1.0
|
CAF
|
B:1FL500
|
3.6
|
27.2
|
0.2
|
CG2
|
B:VAL121
|
3.8
|
36.3
|
1.0
|
CAH
|
B:1FL500
|
3.8
|
25.1
|
0.2
|
CAJ
|
B:1FL500
|
3.9
|
27.8
|
0.2
|
CB
|
B:ALA108
|
3.9
|
28.8
|
1.0
|
OAL
|
B:1FL500
|
4.2
|
27.3
|
0.2
|
CAG
|
B:1FL500
|
4.2
|
23.8
|
0.2
|
CA
|
B:THR119
|
4.3
|
28.9
|
1.0
|
CAN
|
B:1FL500
|
4.3
|
27.2
|
0.2
|
CAI
|
B:1FL500
|
4.3
|
27.4
|
0.2
|
CAR
|
B:1FL500
|
4.4
|
27.1
|
0.2
|
C
|
B:THR119
|
4.4
|
28.9
|
1.0
|
CAG
|
B:1FL500
|
4.6
|
29.5
|
0.2
|
O
|
B:THR119
|
4.6
|
27.5
|
1.0
|
FAE
|
B:1FL500
|
4.7
|
27.7
|
0.2
|
N
|
B:THR119
|
4.8
|
28.1
|
1.0
|
FAT
|
B:1FL500
|
4.9
|
29.2
|
0.2
|
N
|
B:ALA120
|
5.0
|
29.1
|
1.0
|
|
Fluorine binding site 7 out
of 8 in 3d2t
Go back to
Fluorine Binding Sites List in 3d2t
Fluorine binding site 7 out
of 8 in the Human Transthyretin (Ttr) Complexed with Diflunisal
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Human Transthyretin (Ttr) Complexed with Diflunisal within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F500
b:28.1
occ:0.25
|
FAE
|
B:1FL500
|
0.0
|
28.1
|
0.2
|
OAL
|
B:1FL500
|
0.5
|
27.5
|
0.2
|
CAF
|
B:1FL500
|
1.4
|
26.9
|
0.2
|
CAK
|
B:1FL500
|
1.4
|
27.4
|
0.2
|
CAJ
|
B:1FL500
|
2.2
|
27.6
|
0.2
|
CAG
|
B:1FL500
|
2.3
|
29.5
|
0.2
|
CAM
|
B:1FL500
|
2.4
|
27.0
|
0.2
|
OAB
|
B:1FL500
|
2.5
|
27.2
|
0.2
|
CAR
|
B:1FL500
|
2.5
|
27.1
|
0.2
|
CAC
|
B:1FL500
|
2.7
|
27.6
|
0.2
|
CD2
|
B:LEU110
|
3.3
|
25.8
|
1.0
|
CAI
|
B:1FL500
|
3.5
|
27.4
|
0.2
|
CAH
|
B:1FL500
|
3.5
|
27.6
|
0.2
|
CAN
|
B:1FL500
|
3.6
|
27.2
|
0.2
|
CAQ
|
B:1FL500
|
3.7
|
27.2
|
0.2
|
CB
|
B:SER117
|
4.0
|
28.1
|
1.0
|
OAD
|
B:1FL500
|
4.1
|
27.4
|
0.2
|
CAO
|
B:1FL500
|
4.2
|
27.5
|
0.2
|
CAP
|
B:1FL500
|
4.2
|
27.9
|
0.2
|
CB
|
B:LEU110
|
4.3
|
26.1
|
1.0
|
OG
|
B:SER117
|
4.3
|
31.8
|
1.0
|
CG
|
B:LEU110
|
4.4
|
25.9
|
1.0
|
FAT
|
B:1FL500
|
4.8
|
29.2
|
0.2
|
|
Fluorine binding site 8 out
of 8 in 3d2t
Go back to
Fluorine Binding Sites List in 3d2t
Fluorine binding site 8 out
of 8 in the Human Transthyretin (Ttr) Complexed with Diflunisal
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 8 of Human Transthyretin (Ttr) Complexed with Diflunisal within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F500
b:27.7
occ:0.25
|
FAE
|
B:1FL500
|
0.0
|
27.7
|
0.2
|
OAL
|
B:1FL500
|
0.9
|
27.3
|
0.2
|
CAF
|
B:1FL500
|
1.4
|
27.2
|
0.2
|
CAK
|
B:1FL500
|
1.7
|
27.1
|
0.2
|
OAB
|
B:1FL500
|
2.1
|
25.0
|
0.2
|
CAJ
|
B:1FL500
|
2.1
|
27.8
|
0.2
|
CAC
|
B:1FL500
|
2.3
|
28.1
|
0.2
|
CAG
|
B:1FL500
|
2.4
|
23.8
|
0.2
|
CAM
|
B:1FL500
|
2.4
|
26.5
|
0.2
|
O
|
B:HOH557
|
2.7
|
63.3
|
1.0
|
CAR
|
B:1FL500
|
2.9
|
26.4
|
0.2
|
CAI
|
B:1FL500
|
3.4
|
27.4
|
0.2
|
CAH
|
B:1FL500
|
3.6
|
25.1
|
0.2
|
CAN
|
B:1FL500
|
3.6
|
26.8
|
0.2
|
OAD
|
B:1FL500
|
3.7
|
27.3
|
0.2
|
CAQ
|
B:1FL500
|
4.0
|
26.7
|
0.2
|
CAO
|
B:1FL500
|
4.2
|
26.5
|
0.2
|
CAP
|
B:1FL500
|
4.3
|
27.3
|
0.2
|
CD
|
B:LYS15
|
4.5
|
35.4
|
1.0
|
CG2
|
B:VAL121
|
4.7
|
36.3
|
1.0
|
FAT
|
B:1FL500
|
4.7
|
29.7
|
0.2
|
NZ
|
B:LYS15
|
4.8
|
40.6
|
1.0
|
CG2
|
B:THR106
|
4.8
|
33.2
|
1.0
|
|
Reference:
S.L.Adamski-Werner,
S.K.Palaninathan,
J.C.Sacchettini,
J.W.Kelly.
Diflunisal Analogues Stabilize the Native State of Transthyretin. Potent Inhibition of Amyloidogenesis. J.Med.Chem. V. 47 355 2004.
ISSN: ISSN 0022-2623
PubMed: 14711308
DOI: 10.1021/JM030347N
Page generated: Wed Jul 31 17:40:10 2024
|